Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2022 · 10-Q
Revenue$290.38M$290.38M+19.2% vs Q3 2021 Net Income$60.74M$60.74M+32.7% vs Q3 2021 EPS Diluted$0.37$0.37−67.0% vs Q3 2021 Gross Profit$201,458,000+19.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$73,128,000−2.3% Free Cash Flowderived$58,028,000−9.7% Margins · derivedGross margin69.4%+0.3 pt vs Q3 2021
Operating margin31.1%+3.0 pt vs Q3 2021
Net margin20.9%+2.1 pt vs Q3 2021
ended Mar 31, 2022 · filed May 9, 2022 · 39 d after period end